Respiratory Syncytial Virus burden of disease in older adults and prevention
-
Location
Zoom-US
-
Phone
+966 112790305
- Website: www.credit-hours.com Join Event
- Email Address: info@credit-hours.com
- Email Activity Coordinator: cpd2@credit-hours.com
- Phone Activity Coordinator: +966 598987505
Event Audience
- Infection Control
- Infectious Disease
- Hematology
- Medical Oncology
- Family Medicine
- Internal Medicine
- Emergency Medicine
- Otorhinolaryngology (ENT)
- General Practice
- Neurology
- Thoracic and Cardiac Surgery
- Cardiac Surgery
- Critical Care Medicine
- Allergy and Immumology
- Cardiology
- Pulmonology
- Public Health
- Geriatric Medicine
- Hematological Pathology
- Thoracic Surgery
- Nephrology
- Rheumatology
- Endocrinology
- Epidemiology
- Renal transplant
- Epidemiology
- Preventive Medicine
- Family and Community Medicine
- Midwifery
- Nursing
- Adult Critical Care Nursing
- Nursing Administration
- Primary Health Care Nursing
- Nursing Education
- Pain Management Nursing
- Cardiovascular Nursing
- Hemodialysis Nursing
- Geriatric Nursing
- Emergency Care Nursing
- Community and Public Health Nursing
- Disaster and Emergency Nursing
- Home Health Care
- Emergency and Disaster Nursing Administration
- Pharmaceutical Sciences
- Clinical Pharmacy
- Pharmaceutical administration AND outcomes
- Pharmacy
- Respiratory Therapy
Event Goals
- • Discuss the recent guidelines and recommendations about RSV diagnosis, management and preventive measures
- •Interpret recent clinical trial data on RSV vaccines, comparing their effectiveness in preventing lower respiratory tract disease (LRTD) and severe RSV outcomes.
- •Analyze the challenges and barriers to RSV vaccine implementation in clinical settings, proposing strategies to improve vaccination coverage among older adults.
- •Describe the risk factors and comorbidities that increase the severity of RSV in elderly patients, enabling healthcare professionals to identify high-risk individuals for vaccination.
- •Illustrate best practices in patient counselling for RSV vaccination, equipping HCPs with communication strategies to address patient concerns and improve vaccine uptake.
- •Compare RSV prevention strategies with those of other respiratory infections like influenza, demonstrating the importance of a comprehensive immunization approach in elderly care.
- •Discuss the role of the newly approved adjuvanted recombinant RSV vaccine in Saudi Arabia, highlighting its efficacy, safety profile, and recommended use in high-risk populations.
Event Agenda
04/05/2025
Welcome and Introduction
18:00:00 - 18:10:00
Speaker(s):
No speakers assigned
04/05/2025
Pre-test to assess the current knowledge
18:15:00 - 18:25:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Common Causes of Lower Respiratory Tract Infection
18:35:00 - 18:55:00
Speaker(s):
ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Epidemiology of Respiratory syncytial virus (RSV)
19:00:00 - 19:20:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Respiratory syncytial virus (RSV) burden of hospitalization and death
19:25:00 - 19:45:00
Speaker(s):
ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Clinical Outcomes and Co-Morbidities
20:00:00 - 20:20:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Challenges to identifying morbidity burden in older adults and children
20:25:00 - 20:45:00
Speaker(s):
ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Break
21:00:00 - 21:15:00
Speaker(s):
No speakers assigned
04/05/2025
Respiratory syncytial virus (RSV) vs. Influenza Burden
21:20:00 - 21:40:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Current Limitations of RSV Prevention, Overall and in at-Risk Populations.
22:00:00 - 22:15:00
Speaker(s):
ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Emerging Opportunities to Support Ongoing Development of RSV Treatment and Prevention Interventions
22:15:00 - 22:30:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Case Study on Respiratory Syncytial Virus (RSV) and Immunocompromised Patients
22:30:00 - 22:45:00
Speaker(s):
ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Case Study on Respiratory Syncytial Virus (RSV) and Patients with heart failure
22:45:00 - 23:00:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Break
23:00:00 - 23:10:00
Speaker(s):
No speakers assigned
04/05/2025
Case-based Discussion and Q/A session
23:10:00 - 23:35:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
, ريم محمود الأمير (REEM MAHMOUD ALAMEER)
04/05/2025
Post-Test
23:35:00 - 23:45:00
Speaker(s):
اشرف عبدالقيوم امير (ASHRAF ABDULQAYOUM AMIR)
04/05/2025
Take home messages and Closure
23:50:00 - 23:59:00
Speaker(s):
No speakers assigned
© 2024 Marvel Developed by Marvel Development Team